Cargando…
Ingenol mebutate treatment in actinic keratosis – clinical effectiveness and potential side effects
INTRODUCTION: Actinic keratosis is a common skin disease that occurs in response to prolonged exposure to ultraviolet radiation. This problem affects up to 60% of the population over 40 years of age. Actinic keratosis is considered to be a precancerous lesion leading to squamous cell carcinoma (SCC)...
Autores principales: | Lesiak, Aleksandra, Maćkowska, Anna, Bednarski, Igor A., Kolano, Paweł, Olejniczak-Staruch, Irmina, Woźniacka, Anna, Sieniawska, Joanna, Narbutt, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791158/ https://www.ncbi.nlm.nih.gov/pubmed/31616223 http://dx.doi.org/10.5114/ada.2019.87450 |
Ejemplares similares
-
Omalizumab for urticaria treatment in clinical practice: a case series
por: Lesiak, Aleksandra, et al.
Publicado: (2018) -
Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013) -
Interleukin 22 and 6 serum concentrations decrease under long-term biologic therapy in psoriasis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2020) -
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012) -
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017)